Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Spinal cord stimulation offers relief for patients who have not responded to other treatments for chronic neuropathic pain. Spinal cord stimulation devices reduce the need for opioid-based pain ...

However, concerns regarding softness in the spinal cord stimulation ... aimed at treating chronic pain caused by the SI joint, a common source of lower back pain, Nevro seeks to address a ...

Globus Medical Inc. reported it is buying Nevro Corp. in an all-cash transaction. Under the terms of the agreement, which was unanimously approved by the boards of both companies, Globus will acquire ...

In September 2024, Nevro gained approval from the US Food and Drug Administration (FDA) for HFX AdaptivAI, a personalised pain management ... s Wavewriter spinal cord stimulator systems, for ...